PROGRAM ONE
Cardiovascular Heathcare Policy: Charting the Future
James T. Dove, MD, MACC
ACC and STS: A Timely Collaboration
W. Randolph Chitwood, Jr., MD
Debate: Treatment of Atherosclerosis
-Time to Think Beyond LDL Treatment
P.K. Shah, MD
-LDL is the Major Therapeutic Target
H. Robert Superko, MD
Coronary Microvascular Disease: Real Disease Entity Which Requires Specific Treatment?
C. Noel Bairey Merz, MD
Aortic Valve Repair is Durable and Safe
Hans-Joachim Shäfers, MD, PhD
top
PROGRAM TWO
Cross Fire: Renal Artery Stenosis Treatment by Stenting
-A Missed Opportunity?
Robert M. Bersin, MD, MPH
-Overused in Absense of Evidence
Satyendra Giri, MD
-What about Surgery?
Jerry Goldstone, MD
Cross Fire: Asymptomatic Carotid Artery Stenosis
-Vascular Surgeon's Perspective
Bruce L. Gewertz, MD
-Interventionalist's Perspective
Satyendra Giri, MD
-Medical Treatment Perspective
Robert M. Bersin, MD
PharmacoGenomics: Is it the Future of Medicine?
Eric Topol, MD
Cross Fire: Treatment of Atrial Fibrillation (cont'd on Program Three)
-Medical Management Remains the Best Option for Most Patients
Sumeet Chugh, MD
-Primary Ablation Carries Low Risk and Great Benefits
Niv Ad, MD
top
PROGRAM THREE
Cross Fire: Treatment of Atrial Fibrillation (cont'd from Program Two)
-Primary Ablation Carries Low Risk and Great Benefits
Niv Ad, MD
-Optimal Management Includes Early Surgical Consideration
Randall K. Wolf, MD
Biologic Pacemakers: From Bench to Bedside?
Eduardo Marbán, MD, PhD
Debate: Sudden Death Treatment
-ICDs are Effective and Underutilized
Charles D. Swerdlow, MD
-ICD Costs Outweigh the Modest Benefits
Sumeet Chugh, MD
Debate: Cell-therapy for Myocardial Disease
-A Promising Therapy with Tremendous Potential
Keith Horvath, MD
-Another Hype, Soon to be Forgotten
James Forrester, MD
top
PROGRAM FOUR
Endocarditis Prophylaxis: Current Standards and Remaining Controversies
Ann F. Bolger, MD
Cross Fire: Current and Future Approach to the Treatment of Mitral Valve Regurgitation
-Classic Mitral Valve Repair
Alfredo Trento, MD
-Robotic Minimally Invasive Mitral Valve Repair
W. Randolph Chitwood, Jr., MD
-Percutaneous Edge-to-edge Repair
Saibal Kar, MD
-Emerging Technologies will Supercede Traditional Approaches
William E. Cohn, MD
Treatment of Mitral Regurgitation: Putting the Percutaneous Treatment of MR in Perspective
Ted Feldman, MD
Debate: Are we Under-treating Mitral Valve Regurgitation?
-Protagonist
Steven Khan, MD
-Antagonist
Robert J. Siegel, MD
top
PROGRAM FIVE
A Tribute to Andreas Gruentzig: A 30-year Odyssey and His Legacy of PCI
Spencer B. King, III, MD
Next Generation of Drug Eluting Stents: Is it the Solution?
Eberhard Grube, MD
Safety and Efficacy of PCI without Onsite Surgery & Other Clinical Lessons Learned from the NCDR
Ralph G. Brindis, MD, MPH
Cross Fire: Drug Eluting Stents
-Efficacy Clearly Outweighs Safety Concerns
Gregg W. Stone, MD
-Safety Still a Major Concern
Spencer B. King, III, MD
-Why Do I Dislike Drug Eluting Stents?
David Taggart, MD, PhD
top
PROGRAM SIX
Cross Fire: Multi-vessel Coronary Artery Disease
-Surgical Protagonist
David Taggart, MD, PhD
-PCI Protagonist
Paul S. Teirstein, MD
-Medical Protagonist
Sanjay Kaul, MD
Debate: Left Main Coronary Artery Disease
-Surgical Protagonist
Michael J. Mack, MD
-PCI Protagonist
Raj Makkar, MD
A Vaccine for Atherosclerosis: Promise for the Future? (cont'd on Program Seven)
P.K. Shah, MD
top
PROGRAM SEVEN
A Vaccine for Atherosclerosis: Promise for the Future? (cont'd from Program Six)
P.K. Shah, MD
Cross Fire: Treatment Options for Aortic Stenosis
-Prosthetic Valves are Tried and True
Michael J. Mack, MD
-Surgical Replacement via Limited Incision
Gregory P. Fontana, MD
-Percutaneous AVR
Eberhard Grube, MD
-Percutaneous AVR: An Update on Edward-Sapien Valve
Raj Makkar, MD
-Transapical Catheter AVR
Anson Cheung, MD
Treatment of Aortic Stenosis: Putting Percutaneous Treatment of Aortic Stenosis Into Perspective
John G. Webb, MD
Cardiac Imaging: Next Opportunities and Challenges
Jagat Narula, MD
top
PROGRAM EIGHT
Debate: Are we Under-treating Aortic Stenosis
-Protagonist
Steven Khan, MD
-Antagonist
Robert J. Siegel, MD
Exercise and the Heart: The Risk to Benefit Ratio
Alfred A. Bove, MD, PhD
Debate: PFO Closure for Cryptogenetic Stroke
-Protagonist
Mark Reisman, MD
-Antagonist
Jonathan M. Tobis, MD
Debate: Training by Catheter Techniques for Surgeons
-Endovascular Training is Integral to the Future Surgeon
Mathew R. Williams, MD
-Surgeons Should Stick to the Knife and be Good at Using It
David Taggart, MD, PhD
top
